CYTO News and Press, Altamira Therapeutics Ltd. From 11/03/23

2023-11-03 07:33:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to dive into the biggest pre-market stock movers for Friday with all the shares worth watching today! Moving stocks this morning are earnings reports, a shareholder meeting...

HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) -- Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy and tolerability of Bentrio® nasal spray in treatment of seasonal allergic rhinitis Study meets both primary and secondary efficacy...

2023-09-13 10:54:47 ET More on Altamira Therapeutics Financial information for Altamira Therapeutics Altamira Therapeutics Ltd. ( CYTO ) Q2 2023 Earnings Call Transcript For further details see: Altamira Therapeutics reports 1H results

2023-09-12 12:15:23 ET Altamira Therapeutics Ltd. (CYTO) Q2 2023 Earnings Conference Call September 12, 2023 08:00 AM ET Company Participants Thomas Meyer - Founder, Chairman & CEO Covadonga Paneda - Chief Operating Officer Conference Call Participants ...

HAMILTON, BERMUDA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Company hosts 1H 2023 Financial Results and Business Update call today at 8 a.m. ET First research collaboration with biopharmaceutical company initiated for OligoPhore™ platform Partnering discussions for legacy asse...

Farmer Brothers Company (FARM) is expected to report $-0.61 for Q4 2023 Aspen Group Inc. (ASPU) is expected to report for Q1 2023 Kaspien Holdings Inc. (KSPN) is expected to report for Q1 2024 AGC Inc ADR (ASGLY) is expected to report for Q2 2023 Shimano Inc. ADR (SMNNY) is expect...

Altamira Therapeutics Ltd. (CYTO) is expected to report for quarter end 2023-06-30

2023-09-10 10:43:13 ET More on next week's earnings: Compare metrics for ADBE to CBRL, EGIO, FCEL, LEN, ORCL Oracle: The Problem With All The Hype Around AI Oracle: Optimistic Valuation, Yet The Company Has To Deliver Oracle Is Not An AI Wannabe, But Is ORCL ...

HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced that it will host its First Half of 2023 Financial Results and ...

HAMILTON, BERMUDA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its founder, Chairman, and CEO Thomas Meyer will be present...